Comparative Pharmacology
Head-to-head clinical analysis: ATROPINE versus VALPIN 50.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ATROPINE versus VALPIN 50.
ATROPINE vs VALPIN 50
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Competitive antagonist of muscarinic acetylcholine receptors (M1, M2, M3, M4, M5), blocking the effects of acetylcholine and other cholinergic agonists. Inhibits vagal activity, increases heart rate, reduces secretions, and relaxes smooth muscle.
VALPIN 50 (anisotropine methylbromide) is an anticholinergic agent that competitively inhibits the action of acetylcholine at muscarinic receptors, thereby reducing gastrointestinal motility and secretion.
0.5-1 mg IV/IM/SC every 3-5 minutes as needed, up to a total of 3 mg (adults). For preoperative use, 0.4-0.6 mg IM/IV 30-60 minutes before anesthesia.
50 mg orally three to four times daily.
None Documented
None Documented
Clinical Note
moderateBenzatropine + Haloperidol
"The metabolism of Haloperidol can be decreased when combined with Benzatropine."
Clinical Note
moderateBenzatropine + Fluconazole
"The metabolism of Fluconazole can be decreased when combined with Benzatropine."
Clinical Note
moderateBenzatropine + Clotrimazole
"The metabolism of Clotrimazole can be decreased when combined with Benzatropine."
Clinical Note
moderateBenzatropine + Dronedarone
2-4 hours (terminal); prolonged in elderly and neonates; clinically requires dosing every 4-6 hours
Terminal elimination half-life: 20-30 hours. Clinical context: Allows once-daily dosing in nocturia; prolonged in renal impairment, requiring dose adjustment.
Renal (30-50% unchanged; remainder as inactive metabolites via hydrolysis and glucuronidation); 50-70% of a dose renally excreted as metabolites; <5% fecal
Primarily renal (unchanged drug and metabolites): 80-90%; biliary/fecal: 10-20%.
Category C
Category C
Anticholinergic Agent
Anticholinergic Agent
"The metabolism of Dronedarone can be decreased when combined with Benzatropine."